Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Open in API
Filings indexed 830 across all filing types
Latest filing 2020-03-05 Director's Dealing
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-03-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text specifically mentions a press release about the submission of a New Drug Application (NDA) to the FDA. The document is short (3694 characters) and primarily serves to announce this event and furnish the press release as an exhibit. There are no financial statements or detailed financial data included. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories. It is not an Annual Report, Earnings Release, or any other detailed financial report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-03-02 English
FORM S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by KemPharm, Inc. on February 28, 2020. It registers additional shares of common stock under the company's 2014 Equity Incentive Plan. The document includes details about the registration fee, incorporation by reference of prior filings, exhibits related to corporate governance documents, and signatures of company officers. Form S-8 is a specific SEC filing used to register securities to be offered under employee benefit plans, which is a type of capital/financing update related to equity compensation plans. It is not an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2020-02-28 English
FORM 10-K
Annual Report FY 2019
2020-02-28 English
Regulatory Filings 2020
Regulatory Filings
2020-02-28 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated February 28, 2020. It announces the issuance of a press release reporting the company's financial results for the fourth quarter and full year ended December 31, 2019. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The text explicitly states that the press release is furnished and not filed for purposes of the Exchange Act, indicating this document is an announcement of financial results rather than the full earnings release or annual report itself. Given the short length (3647 characters) and the nature of the content, this fits the category of an Earnings Release (ER) announcement within a Form 8-K. Therefore, the classification is Earnings Release (ER) with high confidence.
2020-02-28 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.